GW823093 Japan Phase IIa Mono

Trial Profile

GW823093 Japan Phase IIa Mono

Phase of Trial: Phase II

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Denagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 20 Oct 2009 Planned end date (1 Oct 2007) added as reported by
    • 15 Oct 2008 Actual start date changed from Apr 2006 to May 2006 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top